News
Pathological Changes in the Tracheobronchial Tree after Routine Tracheal Aspiration The tracheobronchial trees of 8 patients who died eighteen to ninety-six hours after tracheotomy were examined.
Hosted on MSN8mon
FDA grants marketing authorisation to Peytant’s AMStent systemPeytant Solutions has received marketing authorisation from the US Food and Drug Administration (FDA) for its AMStent tracheobronchial covered stent system.
Interventional pulmonology is a new field within pulmonary medicine focused on the use of advanced bronchoscopic and pleuroscopic techniques for the treatment of a spectrum of thoracic disorders ra ...
A 73-year-old woman with tracheobronchial amyloidosis (TBA) was referred for consideration of external beam radiation therapy (EBRT). She was diagnosed more than 20 years previously when she was ...
Relapsing polychondritis (RP) is a rare auto-immune disease, characterized by inflammatory flare-ups of cartilaginous tissues, associated with systemic manifestations. This review is ...
Endoprosthesis (Viatorr) for TIPS Procedures and Tracheobronchial Strictures On Dec. 8, the FDA approved an implantable device (Viatorr Endoprosthesis, made by W. L. Gore & Associates, Inc.) for ...
All patients were treated thoracoscopically without resorting to open surgery and were discharged without any postoperative complications within 16 days (range: 8-22 days). The minimally invasive ...
Tracheobronchial aspiration is a potentially life-threatening complication of enteral feeding A malpositioned nasogastric tube, improper feeding site, large gastric volume and supine position are the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results